NantHealth Return on Equity

NantHealth (NHIQ) currently reports a ROE of 28.13%. That is below the Technology sector average of 47.48%. Use the charts on this page to explore NantHealth's ROE history and peer comparisons.

NantHealth's ROE of 28.13% is lower than the Technology sector average of 47.48%. That is roughly 40.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but NantHealth's current 28.13% should be judged against Technology norms (sector average: 47.48%) and against NHIQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 28.13%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.48%. From there, open related valuation or income-statement pages for NantHealth, and consider following NHIQ for alerts when major investors trade the stock.

NantHealth is classified in the Technology sector. On ROE, it currently shows 28.13% versus a sector average near 47.48%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NHIQ with unrelated industries.